Title: Exploring the Relationship of Drugs/Dietary Factors/Obesity in Occurence of Nonalcoholic Fatty Liver Disease
Authors: Rajashree Samal, Sweekruti Jena, Kaliprasad Pattnaik, Chitta Ranjan P, Srikanta Mohanty
DOI: https://dx.doi.org/10.18535/jmscr/v5i4.87
Abstract
Nonalcoholic fatty liver disease is one of the common liver diseases worldwide, with a high prevalence in the obese, with faulty dietary habits & persons taking frequent medications & it is probably underestimated as a cause of life threatening complications like, cirrhosis, hepatocellular Carcinoma etc.79 patients of either sex between 10-65yrs of age, incidentally found to have fatty liver by ultrasonography, referred to Radiology and Gastroenterology departments were the study population. The lifestyle pattern. Biochemical tests, like liver function test, serum lipid profile & fasting blood sugar (FBS) were checked for all patients. Anthropometric data including weight & height were recorded. The BMI value>25kg/m2 was considered as risk factor. History about the diet & use of medications including alternative medicines known to cause fatty liver disease were recorded. The degree of steatosis was graded ultrasonographically by a single Radiologist from 0-3.This study of two months duration concluded that is often asymptomatic and is an incidental finding during ultrasonography of liver on routine screening. In the absence of established therapies it can be treated by modifying the risk factors. We identified the modifiable risk factors like BMI, dietary pattern associated with Non-alcoholic Fatty Liver Disease. Standard diet therapy, lifestyle modification could be used as an effective treatment for NAFLD patients. Minimising intake of fast food, soft drinks and non-vegetarian spicy diet will also help to maintain a healthy lifestyle.
Key Words: Non Alcoholic Fatty Liver Disease, Obesity, Ultrasonography.
References
1. Farrel GC, LarterCZ. Nonalcoholic Fatty Liver disease from steastosis tocirrhosis. Hepatology 2006; 43:S00-S112
2. Day CP, ZamesOF !steato hepatitis : a tale of two “ Hits “ ? Gastroenterology 114(4): 842-845, 1998
3. ShiraZelber-Sagi, VladRatziu, and Ran Oren Nutrition and physical activity in NAFLD: An overview of the epidemiological evidence. World J Gastroenterol.2011 August7; 17(29):3377-3389.
4. DAVID A,SASS,MD,PARKE CHANG, MD, and KAPIL B.CHOPRA, MD. Nonalcoholic Fatty Liver Disease: A Clinical Review. Digestive Diseases and Sciences, Vol.50.No.1 (January 2005), pp.171-180.
5. Mohan V, Deepa R. Adipocytokines and the expanding << Asian Indian Phenotype >> J Assoc Physic Ind. 2006 ; 54 : 685-6.
6. 6. Joseph AE, Saverymuttu SH, al-sam S, Cook MG, Maxwell JD.Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. ClinRadiol 1991; 43:26-31.
7. Itoh S, Tsukada Y, Motomura Y, Ichinoe A. Five patients with nonalcoholic diabetic cirrhosis. Acta Hepatogastroenterol Stuttg1979; 26:90–97.
8. Angulo P, Lindor KD: Non-alcoholic fatty liver disease. J GastroenterolHepatol 17 (Suppl):S186–S190, 2002.
9. Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, Bogardus C, Tataranni PA. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes2002; 51: 1889-1895.
10. Gupte P, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, Pramanik S, Patel N, MadanA,Amarapurkar A, Hafeezunnisa. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. Gastroenterol Hepatol 2004; 19: 854-858
11. DelGaudio A, Boschi L, Del Gaudio GA, Mastrangelo L, Munari D. Liver damage in obese patients. ObesSurg2002; 12: 802-804
12. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, Omatsu T, Nakajima T, Sarui H, Shimazaki M, Kato T, Okuda J, Ida K. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.Ann Intern Med 2005; 143: 722-728
13. Bogin E, Avidar Y, Merom M. Biochemical changes in liver and blood during liver fattening in rats. J ClinChem Clin Biochem1986; 24: 621-626.
14. ShethSG, Gordon FD, Chopra S: Non alcoholic steatohepatitis. Ann Intern Med 126(2):137-145, 1997.